20/08/2020 11:57 AM

Two services related to compulsory social security insurance, health, unemployment, occupational accident and disease insurance are set to be launched on the national public service portal on August 14, saving at least VND1.65 trillion (US$71.7 million) per year.

19/08/2020 03:34 PM

Many businesses had been delaying social insurance payments due to the impact of the COVID-19 pandemic, according to the Việt Nam Social Security (VSS).

19/08/2020 08:32 AM

According to Vietnam Social Security (VSS), although the number of voluntary SI participants increased rapidly in the last year, this number still did not match its potential; thus 2020 will be an important transitional year to achieve a development goal by 2021 for voluntary social insurance (SI) defined in Resolution No. 28-NQ/TW (farmers and informal-sector laborer participating in voluntary SI making up about 1% of working age workforce).

18/08/2020 02:05 PM

Viet Nam always pushes priorities on agenda and initiatives related to women and girls, especially amid the global health crisis worsened by natural disasters and climate change.

18/08/2020 11:25 AM

The HCM City Centre for Disease Control and Prevention announced on Saturday (August 15) that the collection of samples for Covid-19 testing and health declarations from people returning to the city from Đà Nẵng since July 1 has been completed.

18/08/2020 09:10 AM

H’re ethnic people in mountainous districts of the central Quảng Ngãi Province have an improved awareness of measures to combat the COVID-19 pandemic thanks to the efforts of local officials.

18/08/2020 08:47 AM

In order to reduce difficulties for employers and employees caused by the impact of the COVID-19 crisis, Viet Nam Social Security (VSS) has provided guidance on postponing payment of contributions to retirement and survivor benefit funds. Under the circumstances, will the maternity benefit be affected given that many employees have experienced the interrupted duration of social insurance contribution?

17/08/2020 10:14 AM

Indian drug firms like Lupin, Marksans Pharma, Aurobindo Pharma and Alembic Pharmaceuticals are recalling products in the US market, as per the latest enforcement report by the US Food and Drug Administration (USFDA). While Lupin and Marksans Pharma are recalling diabetes drug, Aurobindo and Alembic are recalling psychiatric medication in the US market.